Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2004
09/08/2004EP1453949A2 Production of cell suspensions
09/08/2004EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof
09/08/2004EP1453856A1 Beta-amyloid binding factors and inhibitors thereof
09/08/2004EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
09/08/2004EP1453837A2 Targeted therapeutics and uses thereof
09/08/2004EP1453832A1 Ring fused pyrazole derivatives
09/08/2004EP1453827A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
09/08/2004EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents
09/08/2004EP1453811A2 Peroxisome proliferator activated receptor agonists
09/08/2004EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
09/08/2004EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
09/08/2004EP1453795A2 Esters and amides as ppar-alpha agonists
09/08/2004EP1453791A1 Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same
09/08/2004EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
09/08/2004EP1453788A1 Substituted hydroxyethylamines
09/08/2004EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents
09/08/2004EP1453777A1 Functionalized higher diamondoids
09/08/2004EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis
09/08/2004EP1453539A2 Immunotherapeutic methods and systems
09/08/2004EP1453532A2 Taojiks as modifiers of the beta-catenin pathway and methods of use
09/08/2004EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders
09/08/2004EP1453525A1 Selective targeting of apoptotic cells
09/08/2004EP1453524A2 Breathable gas mixtures to change body temperature
09/08/2004EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
09/08/2004EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
09/08/2004EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
09/08/2004EP1453510A2 Neurotransmitter balance chemotherapy
09/08/2004EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
09/08/2004EP1453498A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
09/08/2004EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/08/2004EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances
09/08/2004EP1409510A4 Biological pacemaker
09/08/2004EP1294867B1 Human site-1 protease promoter
09/08/2004EP1289972B1 Serine protease inhibitors
09/08/2004EP1289950B1 Serine protease inhibitors
09/08/2004EP1201664B1 Benzimidazole compounds and drugs containing the same
09/08/2004EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes
09/08/2004EP1150746B1 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
09/08/2004EP1140933B1 Process for preparing n6-substituted deaza-adenosine derivatives
09/08/2004EP1137662B1 Pharmaceutical compositions comprising quinapril magnesium
09/08/2004EP1122243B1 Novel imidazoles with anti-inflammatory activity
09/08/2004EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
09/08/2004EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
09/08/2004EP1075474B1 Process for making 1,3-disubstituted-4-oxocyclic ureas
09/08/2004EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis.
09/08/2004EP0873131B1 Processes for preparation of rg3 and rg5 ginsenosides
09/08/2004EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
09/08/2004EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors
09/08/2004CN1527840A Use of CD 25 binding molecules in steroid-resistant patients
09/08/2004CN1527831A Antagonists of MCP-q function and method of use thereof
09/08/2004CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
09/08/2004CN1527827A Therapeutic heterocyclic compounds
09/08/2004CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
09/08/2004CN1527823A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
09/08/2004CN1527822A Thiazole derivatives for treating PPAR related disorders
09/08/2004CN1527814A Nitric oxide synthase inhibitor phosphate salt
09/08/2004CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents
09/08/2004CN1527727A Improved chelator conjugates
09/08/2004CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis
09/08/2004CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1527707A The use of substituted azetidinone compounds for the treatment of sitosterolemia
09/08/2004CN1527705A Pharma ceutical formulation containing and LTB4 antagonist
09/08/2004CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases
09/08/2004CN1526721A Extraction process of conjugated female hormone
09/08/2004CN1526448A Medicine and method for the treatment of anorectal disorders
09/08/2004CN1526447A Human blood vessel IBP sample growth factor
09/08/2004CN1526433A Compound American ginseng prepn and its prepn process
09/08/2004CN1526432A Medicine for treating piles
09/08/2004CN1526420A Prepn of blood fat reducing granule
09/08/2004CN1526409A Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process
09/08/2004CN1526402A Use of anthraglucorhein in preparing medicine for treating ischemic cerebral vascular diseases
09/08/2004CN1526401A Medicine composition for treating coronary heart disease and its prepn process, use and guality control method
09/08/2004CN1526398A Compound blood pressure reducing prepn containing angiotonin converzyme inhibitor, calcium ion agonist and Estazolam
09/08/2004CN1526393A Hydralazine hydrochloride guttate pills and the prepn
09/08/2004CN1526380A Metoprolol dripping pills and the prepn process thereof
09/08/2004CN1165550C Synthetic polysaccharides, their method of prodn. and pharmaceutical compositions contg. same
09/08/2004CN1165539C Oxazinocarbazoles for the treatment of CNS diseases
09/08/2004CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists
09/08/2004CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
09/08/2004CN1165526C Substituted phenyl cyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
09/08/2004CN1165522C Bradykinin receptor antagonists
09/08/2004CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents
09/08/2004CN1165311C Slow-releasing coposition of estrogen medicine and its preparing process
09/08/2004CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450
09/08/2004CN1165309C Stable compositions comprising levosimendan and alginic acid
09/08/2004CN1165305C Lyophilized composition of nimodipine
09/08/2004CN1165304C Nimudipin undertongue spraying agent
09/08/2004CN1165296C Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or film-forming auxiliary agent
09/07/2004US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents
09/07/2004US6787566 Breakers of advanced glycation endproducts
09/07/2004US6787561 Benzimidazole compounds
09/07/2004US6787560 Serotonin reuptake inhibitor
09/07/2004US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
09/07/2004US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure
09/07/2004US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives
09/07/2004US6787552 PPAR delta activators
09/07/2004US6787551 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
09/07/2004US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
09/07/2004US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder